**Average weight-loss results cited (≈21% for tirzepatide and ≈15–16% for semaglutide) are based on peer-reviewed clinical trials published in leading medical journals, including The New England Journal of Medicine.These outcomes represent mean results achieved under controlled clinical trial conditions with medical supervision and lifestyle guidance.Individual results vary and are not guaranteed.